Tokyo, Basking Ridge, N.J. and Munich – (September 14, 2020) – Daiichi Sankyo Company, Limited (hereafter,…
View More Daiichi Sankyo Initiates Phase 2 Study of Patritumab Deruxtecan in Patients with HER3 Expressing Advanced Colorectal Cancer
Home »
New treatment improves survival in women newly diagnosed with advanced ovarian cancer
An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed…
View More New treatment improves survival in women newly diagnosed with advanced ovarian cancer
Can red cell exchange treat advanced sickle cell disease?
Medical advances have dramatically increased the life expectancy of patients with sickle cell disease, but…
View More Can red cell exchange treat advanced sickle cell disease?
More in-depth tumor analysis presents new therapeutic options for patients with advanced cancer
An international clinical trial, published in Nature Medicine, revealed that combining RNA and DNA profiling…
View More More in-depth tumor analysis presents new therapeutic options for patients with advanced cancer